StockWatch
·
✦ Trending

Impact Events

Live
1d ago, 10:00 pm
Pharmaceuticals
ANUHPHRANUH PHARMA LTD.

Anuh Pharma Inaugurates New Manufacturing Facility

Expansion

Anuh Pharma Limited has inaugurated its new manufacturing facility located at F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar, Maharashtra. The facility, inaugurated on November 15, 2026, is expected to be fully operational by December 2026. This expansion will increase the company's manufacturing capacity by 525 Metric Tons per annum (MT/Annum), bringing the total post-expansion capacity to approximately 2,925 MT/Annum. Additionally, the new plant includes 56 KL of reactor capacity, aimed at meeting growing market demands.

1d ago, 10:00 pm
Industrial Products
DEEDEVDee Development Engineers Ltd

DEE Development Engineers Q2 FY27 PAT ₹23.5 Cr, Up 31.8% YoY

Quarterly Result

DEE Development Engineers reported unaudited financial results for the quarter and half-year ended September 30, 2026. For Q2 FY27, the company posted a Profit After Tax (PAT) of ₹23.5 crore, a 31.8% increase year-on-year, with a PAT margin of 8.0%. Revenue from operations grew 8.5% YoY to ₹293.0 crore, driven by the Piping & Fittings segment. Operating EBITDA rose 33.7% YoY to ₹58.9 crore, with margins at 20.1%. For H1 FY27, revenue was ₹587.4 crore (up 19.0% YoY) and PAT was ₹39.5 crore (up 27.8% YoY). The company's order book stood at ₹2,531 crore as of September 30, 2026, a 93.5% increase YoY. Key operational highlights include progress on building the nuclear piping business through an EPC tie-up and an advanced global JV discussion, alongside a credit rating upgrade by CareEdge to CARE A; Stable. Finance costs declined QoQ after debt repayment.

1d ago, 10:00 pm
Industrial Products
TIPCOTipco Engineering India Ltd

Tipco Engineering Board Meeting on Nov 18, 2026 for Fundraise

Board Meeting

Tipco Engineering India Ltd has announced that its Board of Directors will convene on November 18, 2026. The primary agenda item is to consider and approve a proposal for the issuance of instruments, including equity shares or convertible securities, through methods such as Preferential Issue or Rights Issue. The board will also determine the pricing for these instruments and discuss any other relevant business matters. Concurrently, the trading window for dealing in the company's securities will be closed from the date of the announcement until 48 hours after the board meeting concludes.

1d ago, 10:00 pm
Pharmaceuticals
ANUHPHRANUH PHARMA LTD.

Anuh Pharma Inaugurates New Manufacturing Facility

Expansion

Anuh Pharma Limited has inaugurated a new manufacturing facility at F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar, Maharashtra. The new plant, inaugurated on November 15, 2026, is expected to be fully operational by December 2026. This expansion will increase the company's existing manufacturing capacity by 525 Metric Tons per annum (MT/Annum), bringing the total post-expansion capacity to approximately 2,925 MT/Annum. Additionally, the facility includes 56 KL of new reactor capacity to meet growing market demands.

1d ago, 9:30 pm
Industrial Gases
ELLENEllenbarrie Industrial Gases Ltd

Ellenbarrie Industrial Gases Ltd: Monitoring Agency Report Q3 2026

Corporate Governance

Ellenbarrie Industrial Gases Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026, as per SEBI regulations. The report, issued by CRISIL Ratings Limited, pertains to the utilization of IPO proceeds. The company confirmed that all utilization is in line with the disclosures made in the Offer Document, with no deviations reported. The IPO, which was a public issue of equity shares, had a total issue size of Rs 8,525.25 million, comprising a fresh issue of Rs 4,000.00 million and an Offer for Sale (OFS) of Rs 4,525.25 million. CRISIL Ratings will monitor the gross proceeds from the fresh issue.

1d ago, 9:30 pm
Pharmaceuticals
NATCAPSUQNATURAL CAPSULES LTD.

Natural Capsules Q2 FY27 Results: Revenue Up 5%, PAT ₹3.01 Cr

Quarterly Result

Natural Capsules Limited announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. For Q2 FY27, the company reported a 5% increase in revenue and a Profit After Tax (PAT) of ₹3.01 crore. The Executive Director highlighted a strategic conversion of HPMC lines to gelatine lines, which drove growth due to increased gelatine volumes. Realization improvements from the previous quarter were maintained. The company also reported progress in its API business with a new CEO appointment and a focus on market registrations. Challenges in logistics and rising raw material costs are anticipated, with plans to pass on increases to customers. New customers, including Mankind Pharma, were added, and an audit by Zydus Lifesciences was successfully completed.

1d ago, 9:00 pm
Airport & Airport services
GMRAIRPORTGMR Airports Infrastructure Ltd

GMR Airports Traffic Up 0.3% YoY in Oct 2026

Monthly Update

GMR Airports reported a 0.3% year-on-year increase in total passenger traffic to 10.2 million in October 2026. Domestic traffic saw a slight decrease of 0.7% YoY to 7.6 million, while international traffic grew by 3.4% YoY to 2.5 million. The company noted a significant sequential growth of 10.1% MoM in October traffic. For the Year-to-Date (YTD) FY27, GMR Airports surpassed 68.3 million passengers, marking the highest-ever YTD total. Delhi Airport (DEL) reported its highest-ever YTD volumes across total, domestic, and international passenger traffic, as well as aircraft movements (ATMs) and cargo throughput. Hyderabad Airport (HYD) also achieved its highest-ever YTD cargo throughput. Despite muted international traffic growth attributed to geopolitical instability and subdued domestic growth due to airline route rationalization, the overall performance indicates resilience.

1d ago, 8:30 pm
IT Enabled Services
NPSTNetwork People Services Technologies Ltd

Network People Services Technologies Invests $1M in Subsidiary

Investment

Network People Services Technologies Ltd announced an investment of USD 1,000,000 in its wholly owned subsidiary, NPST Global Solutions LLC (NGS). The investment is made through the subscription of Optionally Convertible Debentures (OCDs) with a 4% annual coupon rate over a 3-year tenure, extendable by two years. This capital infusion is intended to augment NGS's capital base and support its business operations in the UAE, which include computer hardware trading and software design. The transaction is classified as a related party transaction but is conducted at arm's length. The investment is being made under the Automatic Route of the Foreign Exchange Management (Overseas Investment) Rules, 2022, requiring post-facto reporting to the Authorized Dealer Bank.

Open Live